UTHealth Houston researchers awarded $3.4M NIH grant to study pharmaceutical therapies to treat acute respiratory distress syndrome

A four-year, $3.4 million grant to investigate molecular mechanisms and therapeutic treatments for acute respiratory distress syndrome (ARDS) has been awarded to UTHealth Houston researchers by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.

Women less likely than men to receive opportune care after stroke, study finds

Women are less likely than men to receive timely care for strokes caused by blockages in large vessels, known as emergent large vessel occlusion (ELVO), according to researchers with The University of Texas Health Science Center at Houston (UTHealth).

Bringing harmony to chaos: UTHealth trauma surgeon repairs lives

By the time first responders rushed the patient to Red Duke Trauma Institute at Memorial Hermann-TMC, life was already slipping away through a stab wound in the neck. The goal of the team: resuscitate and transfer the patient to the operating room, where Laura J. Moore, MD, with UTHealth, would reconstruct his severed blood vessels.

Planes, trains and automobiles: Reducing the risks of traveling this summer

After enduring more than two months of quarantine, businesses and institutions are reopening, spurring summer travel plans to satisfy the urge to escape confinement. But is it safe to travel with the threat of COVID-19 still lingering? Experts at UT Physicians/UTHealth weigh in.

New chemotherapy drug studied for malignant brain tumor in children

MTX110 is a new formulation of panobinostat, a chemotherapy drug that has shown promise in laboratory models of medulloblastoma, the most common malignant brain tumor in children. Now, MTX110 is the focus of a novel trial that places the therapy directly into the fourth ventricle of the brain to treat patients with recurrent medulloblastoma.

New study found an increased risk of adverse maternal and neonatal outcomes among women delivering after Hurricane Harvey made landfall.

Hector Mendez-Figueroa, MD, first and corresponding author, is available to talk about his research:  New study found an increased risk of adverse maternal and neonatal outcomes among women delivering after Hurricane Harvey made landfall. The study was just published in…